A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy

Clinical trial NCT02924883 · COMPLETED

Trial details

NCT number

NCT02924883

Sponsor

Hoffmann-La Roche

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2016-09-26

Primary completion

2017-12-11

Enrollment

202

View on ClinicalTrials.gov